---
title: "Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290475329.md"
description: "In Bedford, Massachusetts, on June 22, 2026, Ocular Therapeutix, Inc. provided details that they have awarded inducement awards to Ms. Kelley Allison, the newly appointed SVP of Market Access and Health Policy. Ocular, a biopharmaceutical company listed on NASDAQ under the ticker symbol OCUL, focuses on enhancing the retina experience. The awards were granted under Ocular's 2019 Inducement Stock Incentive Plan to secure Ms. Allison's employment, aligning with Nasdaq Listing Rule 5635(c)(4)."
datetime: "2026-06-22T20:08:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290475329.md)
  - [en](https://longbridge.com/en/news/290475329.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290475329.md)
generator: "portal-rs"
---

# Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

In Bedford, Massachusetts, on June 22, 2026, Ocular Therapeutix, Inc. provided details that they have awarded inducement awards to Ms. Kelley Allison, the newly appointed SVP of Market Access and Health Policy. Ocular, a biopharmaceutical company listed on NASDAQ under the ticker symbol OCUL, focuses on enhancing the retina experience. The awards were granted under Ocular's 2019 Inducement Stock Incentive Plan to secure Ms. Allison's employment, aligning with Nasdaq Listing Rule 5635(c)(4).

### Related Stocks

- [OCUL.US](https://longbridge.com/en/quote/OCUL.US.md)

## Related News & Research

- [Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset](https://longbridge.com/en/news/296129081.md)
- [Readystate Asset Management LP Makes New Investment in Ocular Therapeutix, Inc. $OCUL](https://longbridge.com/en/news/294190211.md)
- [Glucotrack regains Nasdaq stockholders’ equity compliance, secures continued listing](https://longbridge.com/en/news/296101788.md)
- [CPS Technologies leases 80,000-sq-ft Attleboro, Massachusetts facility to expand operations](https://longbridge.com/en/news/296531870.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**